MedScape interviewed CAHC’s president, Joel White, for his thoughts on the ten drugs chosen for negotiation:
A vocal critic of Medicare drug negotiations, Joel White, president of the Council for Affordable Health Coverage (CAHC), called the announcement of the 10 drugs selected for negotiation “a hollow victory lap.” A former Republican staffer on the House Ways and Means Committee, White aided with the development of the Medicare Part D plans and has kept tabs on the pharmacy programs since its launch in 2006.
“[N]o one’s costs will go down now or for years because of this announcement” about Part D negotiations, White said in a statement.